martindale.com
Legal Library
|
Biosimilar Bill Reported From Senate Committee by Daniel A. Kracov
Arnold & Porter LLP - Washington Office
Arthur N. Levine
Arnold & Porter LLP - Washington Office
William W. Vodra
Arnold & Porter LLP - Washington Office
Donald Beers
Arnold & Porter LLP - Washington Office
Gregory Levine
Arnold & Porter LLP - Washington Office
|
|
September 17, 2008
Previously published on July 2007
Bipartisan legislation (S. 1695 (the Biologics Price Competition and Innovation Act)) that would create a mechanism for FDA approval of "biosimilar" (also referred to as "follow-on," "comparable," or "biogeneric") biologic products was reported out of the Senate Health, Education, Labor and Pensions (HELP) Committee on June 27, 2007. www.arnoldporter.com
|
The views expressed in this document are solely the views of the author and not Martindale-Hubbell. This document is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance. |
| | View More Library Documents By... | | | |
| | | | Arnold & Porter LLP Overview |
Practice Area Resource Centers
|
|